143 related articles for article (PubMed ID: 2948730)
21. Systemic infusional chemotherapy for liver metastasis: an improved schedule for 5-fluorouracil.
Lokich JJ
Recent Results Cancer Res; 1986; 100():131-9. PubMed ID: 2942991
[TBL] [Abstract][Full Text] [Related]
22. A randomized comparison of doxifluridine and fluorouracil in colorectal carcinoma.
Alberto P; Mermillod B; Germano G; Kaplan S; Weber W; Joss R; Spati B; Martz G; Cavalli F
Eur J Cancer Clin Oncol; 1988 Mar; 24(3):559-63. PubMed ID: 2968263
[TBL] [Abstract][Full Text] [Related]
23. The implantable "Infusaid" infusion pump. The Sydney experience using 5-fluorouracil.
Stephens FO; Crea P; Walker PJ
Med J Aust; 1986 Jan; 144(2):74-7. PubMed ID: 2934612
[TBL] [Abstract][Full Text] [Related]
24. [Human tumor clonogenic assay in human breast cancer].
Kobayashi T; Kuraishi Y; Aiba K; Inoue K
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
[TBL] [Abstract][Full Text] [Related]
25. [Chemotherapy of ovarian cancer based on in vitro (HTCA) and in vivo (nude mice) chemosensitivity testing].
Sagawa T; Yamashita K; Kawamura M; Shimizu T; Haga H; Yorozu Y; Kasamo M; Fujita M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1197-204. PubMed ID: 2411831
[TBL] [Abstract][Full Text] [Related]
26. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
27. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
Cancer; 1994 Mar; 73(6):1562-8. PubMed ID: 8156482
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of human tumor clonogenic and nude mouse-isotope assays in anticancer-agent sensitivity tests].
Hirabayashi N; Nosoh Y; Nishiyama M; Yamaguchi M; Yoshinaka K; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1808-12. PubMed ID: 3929691
[TBL] [Abstract][Full Text] [Related]
30. Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanine.
Presant CA; Denes AE; Liu C; Bartolucci AA
Cancer; 1984 Jun; 53(12):2610-4. PubMed ID: 6372981
[TBL] [Abstract][Full Text] [Related]
31. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary.
Oberfield RA
Recent Results Cancer Res; 1983; 86():49-62. PubMed ID: 6227958
[No Abstract] [Full Text] [Related]
32. Treatment of colorectal hepatic metastases.
Ridge JA; Daly JM
Surg Gynecol Obstet; 1985 Dec; 161(6):597-607. PubMed ID: 2933831
[TBL] [Abstract][Full Text] [Related]
33. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion.
Sigurdson ER; Ridge JA; Daly JM
Surgery; 1986 Aug; 100(2):285-91. PubMed ID: 2943036
[TBL] [Abstract][Full Text] [Related]
34. Clinical management of advanced gastrointestinal cancer.
Moertel CG
Cancer; 1975 Aug; 36(2):675-82. PubMed ID: 168961
[TBL] [Abstract][Full Text] [Related]
35. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
Ishikawa T; Tanaka Y; Ishitsuka H; Ohkawa T
Jpn J Cancer Res; 1989 Jun; 80(6):583-91. PubMed ID: 2527217
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
Patt YZ; Mavligit GM; Chuang VP; Wallace S; Johnston S; Benjamin RS; Valdivieso M; Hersh EM
Cancer; 1980 Jul; 46(2):261-5. PubMed ID: 6446376
[TBL] [Abstract][Full Text] [Related]
37. Regional infusion of fluoropyrimidines for hepatic metastases of colorectal cancer.
Koks CH; Brouwers JR; Sleijfer DT
Pharm Weekbl Sci; 1988 Apr; 10(2):69-75. PubMed ID: 2969092
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of colorectal cancer.
Klaassen DJ
Can J Surg; 1978 May; 21(3):218-20. PubMed ID: 647512
[TBL] [Abstract][Full Text] [Related]
39. Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
Peters GJ; Braakhuis BJ; de Bruijn EA; Laurensse EJ; van Walsum M; Pinedo HM
Br J Cancer; 1989 Mar; 59(3):327-34. PubMed ID: 2522792
[TBL] [Abstract][Full Text] [Related]
40. [Intra-arterial (5-FU/FA and FUDR) versus systemic chemotherapy (5-FU/FA) of non-resectable colorectal liver metastases].
Gassel HJ; Müller HH; Mattes P; Stieger R; Schramm H; Lorenz M
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1458-60. PubMed ID: 9931911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
